The CLN2 Clinical Rating Scale was applied in this study as it is well-accepted within the clinical community and allowed for the alignment of participating clinicians in their interpretation of the vignettes, particularly with respect to the predominant symptoms of CLN2 disease. Here, TPP1 is linked to neuronal ceroid lipofuscinosis 2.